Analogic sells Cedara shares

Cedara Software Corp. announced that Analogic Corp. sold the 4,580,461 shares it held in Cedara, representing approximately 14.6 percent of the company's outstanding shares.
   
Analogic gained net proceeds of over $50 million from its investment in Cedara.
   
In September 2001, Analogic made a $7.5 million investment in Cedara in order to secure access to Cedara's medical imaging software.
   
Cedara recently inked a long-term deal to allow Analogic and its subsidiaries to use its software, and the two companies' sales organizations pledged to promote each other's products.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.